Citadel VL5This page contains information on Citadel VL5 for veterinary use.
The information provided typically includes the following:
- Citadel VL5 Indications
- Warnings and cautions for Citadel VL5
- Direction and dosage information for Citadel VL5
Citadel VL5This treatment applies to the following species:
Campylobacter Fetus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin
Citadel VL5 Indications
Recommended for the prevention of urinary shedding of L. borgpetersenii serovar hardjo (type hardjo-bovis). Vaccinated animals subsequently exposed to L. borgpetersenii serovar hardjo (type hardjo-bovis) have been shown to clear renal infections within 8 weeks of exposure. For vaccination of healthy, susceptible cattle as an aid in the reduction of infertility, delayed conception, or abortion caused by Campylobacter fetus var. venerealis and leptospirosis caused by Leptospira canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae, and L. pomona.
Directions and Dosage: Using aseptic technique, inject 2 mL subcutaneously. Repeat in 14 to 28 days. Calves vaccinated before 6 months of age should be revaccinated at 6 months. A 2 mL booster dose is recommended once annually.
PrecautionsStore out of direct sunlight at 35-45°F (2-7°C). Avoid freezing. Shake well before using. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Anaphylactoid reactions may occur. Antidote: Epinephrine.
Preservatives: Neomycin and thimerosal.
Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO 64506
U.S. Veterinary License No. 124
10 Doses/20 mL
50 Doses/100 mL
NAC No.: 10281672
2621 NORTH BELT HIGHWAY, ST. JOSEPH, MO, 64506-2002
|Every effort has been made to ensure the accuracy of the Citadel VL5 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-02-06